baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

MEDIGENE AG NA O.N./ DE000A1X3W00 /

2024-04-19 5:36:07 PM	Chg. -0.005	Volume	Bid2024-04-19	Ask2024-04-19	Market Capitalization	Dividend Y.	P/E Ratio
1.920EUR	-0.26%	5,805 Turnover: 10,919.125	-Bid Size: -	-Ask Size: -	47.16 mill.EUR	0.00%	-

GlobeNewswire 04-17 Medigene to Present at Upcoming Scientific Conferences

GlobeNewswire 04-08 Medigene Presents Favorable Safety Profile of TCR-T Cells with Costimulatory Switch Protein at AACR ...

GlobeNewswire 04-04 Medigene AG Secures European Patent for its iM-TCR Technology

GlobeNewswire 03-28 Medigene AG Reports Full-Year 2023 Financial Results and Provides Corporate Update

GlobeNewswire 03-19 Medigene AG to participate in the H.C. Wainwright 2nd Annual Cell Therapy Virtual Conference

GlobeNewswire 03-18 Medigene AG to report full year 2023 financial results on March 28, 2024

GlobeNewswire 03-06 Medigene to Present Favorable Safety Profile of TCR-T Cells upon Addition of Costimulatory Switch Pr...

GlobeNewswire 03-04 Medigene AG Expands Patent Portfolio in Japan for iM-TCR Technology to Directly Control TCR-T Safety...

GlobeNewswire 02-29 Medigene Presents at CAR-TCR Summit Europe Showcasing Unique Approach for Development of Differentia...

GlobeNewswire 02-19 Medigene to Present at Upcoming Conferences

GlobeNewswire 02-12 Medigene Announces Indication Selection for the Clinical Development of its Lead 3rd Generation TCR...

GlobeNewswire 2023-12-19 Medigene AG to attend at the 42nd Annual J.P. Morgan Healthcare Conference

GlobeNewswire 2023-11-21 Medigene AG Announces Prioritization of Pipeline and Resource Allocation as well as Extension of Cas...

GlobeNewswire 2023-11-21 Medigene amends 2023 financial guidance

GlobeNewswire 2023-11-04 Medigene presents new data for MDG2011, the first TCR in a novel KRAS library, demonstrating capabil...

GlobeNewswire 2023-10-26 Medigene Reports Financial Results and Corporate Update for Q3 2023

GlobeNewswire 2023-10-23 Medigene presents first pre-clinical data of optimal affinity TCR targeting mKRAS G12V combined with...

GlobeNewswire 2023-10-16 Medigene to present new pre-clinical data for pipeline TCR-T therapies at the ESMO Congress 2023

GlobeNewswire 2023-09-27 Medigene AG Secures European Patent for its PD1-41BB Costimulatory Switch Protein

GlobeNewswire 2023-09-18 Medigene AG Announces Lead Selection for MDG2011 Representing the First TCR-T Therapy of its KRAS Li...

GlobeNewswire 2023-09-11 Medigene AG to present at the Baader Investment Conference 2023

GlobeNewswire 2023-09-05 Medigene AG to present at the H.C. Wainwright 25th Annual Global Investment Conference

GlobeNewswire 2023-08-30 Medigene presents rationale for combining its 3S TCRs with enhancement tools as an approach to impro...

GlobeNewswire 2023-08-23 Medigene Expands Intellectual Property Rights for its Costimulatory Switch Proteins to Additional Im...

GlobeNewswire 2023-08-22 Medigene AG to present at the 8th CAR-TCR Summit in Boston

MEDIGENE AG NA O.N./ DE000A1X3W00 /

If you wish to receive reply to your feedback, please provide your email address.